Undoing HIV's 'invisibility cloak': Revelation of how certain compounds adhere so strongly to HIV’s coat points to a fresh therapeutic approach
- Date:
- February 10, 2012
- Source:
- RIKEN
- Summary:
- Drug researchers hunting for alternative ways to treat human immunodeficiency virus (HIV) infections may soon have a novel target -- its camouflage coat. HIV hides inside a cloak unusually rich in a sugar called mannose, which it uses to slip past the immune system before infecting its host's cells. Recently, however, biochemists discovered a family of chemical compounds that stick strongly to mannose. Understanding how this mechanism works could reveal a way to make drugs adhere to and kill HIV.
- Share:
Drug researchers hunting for alternative ways to treat human immunodeficiency virus (HIV) infections may soon have a novel target -- its camouflage coat. HIV hides inside a cloak unusually rich in a sugar called mannose, which it uses to slip past the immune system before infecting its host's cells. Recently, however, biochemists discovered a family of chemical compounds that stick strongly to mannose. Understanding how this mechanism works could reveal a way to make drugs adhere to and kill HIV. Yu Nakagawa and Yukishige Ito at the RIKEN Advanced Science Institute in Wako and their colleagues from several research institutes in Japan are leading the effort: they have mapped the binding site of the mannose-binding compound pradimicin A1.
Mannose-binding compounds are particularly attractive to drug researchers thanks to their double-action anti-HIV effect. By sticking to mannose in the virus's coat, pradimicin A first freezes HIV's molecular machinery for entering and infecting its host's healthy cells. The virus responds by reducing the mannose in its coat thereby revealing itself to the immune system, which can then attack.
Unraveling just how pradimicin A recognizes mannose, however, has proven surprisingly difficult. In solution, the two components stick together in variously sized small clusters, confounding conventional analytical techniques such as solution-based nuclear magnetic resonance (NMR) and x-ray crystallography. Nakagawa, Ito and their colleagues side-stepped the clumping problem by using solid-state NMR, which allowed them analyze the compounds as solids, rather than in solution.
The research team's approach involved inserting carbon-13, a chemical label, into particular parts of the pradimicin A structure. Carbon-13 boosts the NMR signal wherever it is inserted, so the team could 'walk' around the compound and detect where it interacts most strongly with mannose.
The results revealed that pradimicin A curls up to form a cavity, within which the mannose structure sits. "Our study highlights the benefit of solid-state NMR methodology to investigate this interaction," says Nakagawa. "Solid-state NMR is, at present, the only technique to analyze such a complicated system." Flagging the potential utility of the technique, Nakagawa adds that: "Our analytical strategy might be applicable to other systems that similarly suffer from aggregation in solution."
Meanwhile, solid-state NMR can offer even more in probing mannose-pradimicin A binding, Nakagawa says. Having determined how and where pradimicin A grabs mannose, the team's next step will be to use the technique to identify the specific molecular interactions that bind the pradmicin A to this potential Achilles' heel of HIV.
Journal Reference:
- Yu Nakagawa, Takashi Doi, Yuichi Masuda, K. Takegoshi, Yasuhiro Igarashi, Yukishige Ito. Mapping of the Primary Mannose Binding Site of Pradimicin A. Journal of the American Chemical Society, 2011; 133 (43): 17485 DOI: 10.1021/ja207816h
Cite This Page: